4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001193125-26-126825
Chief Executive Officer sold 24,431 shares at $18.47 ($451,241)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Barrow Robert · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-25 | Sale : show line 1 in the form 10b5-1 | −24,431 | $18.47 | $451,241 | 752,454 | D |
| Open-market sales · 24,431 sh · avg $18.47 · $451,241 | ||||||
Loading xslF345X06/ownership.xml…